Format

Send to

Choose Destination
See comment in PubMed Commons below
Med Clin North Am. 2009 May;93(3):583-604, Table of Contents. doi: 10.1016/j.mcna.2009.02.008.

Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels.

Author information

1
Laboratory of Cardiovascular Science, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA. lakattae@grc.nia.nih.gov

Abstract

The structure and function of arteries change throughout a lifetime. Age is the dominant risk factor for hypertension, coronary heart disease, congestive heart failure, and stroke. The cellular/molecular proinflammatory alterations that underlie arterial aging are novel putative candidates to be targeted by interventions aimed at attenuating arterial aging as a major risk factor for cardiovascular diseases. This review provides a landscape of central arterial aging and age-disease interactions, integrating perspectives that range from humans to molecules, with the goal that future therapies for cardiovascular diseases, such as hypertension, also will target the prevention or amelioration of unsuccessful arterial aging.

PMID:
19427493
PMCID:
PMC2943242
DOI:
10.1016/j.mcna.2009.02.008
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center